课题基金 / 基金详情

CLINICAL TRIALS STUDY GROUP

CLINICAL TRIALS STUDY GROUP
临床试验研究组
批准号：
3822578
负责人：
MICHAEL M LEDERMAN
金额：
$0.0万
依托单位：
CASE WESTERN RESERVE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3822578
关键词：
AIDS antiAIDS agent antiviral agents cellular immunity combination chemotherapy communicable disease control drug screening /evaluation human immunodeficiency virus 1 human subject human therapy evaluation immunologic skin test immunomodulators leukocyte activation /transformation microorganism disease chemotherapy secondary infection virus antigen virus classification

项目摘要

项目成果

MICHAEL M LEDERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The physician/patient relationship and prevention of AIDS. This aspect of the program is already under active development in the Cleveland area. We will create an outreach educational program for physicians designed around a video tape that emphasizes the public health and preventive educational aspects of AIDS. It will encourage physicians to actively incorporate AIDS information into their daily practices and to serve as resources to the community. It will also include a novel public education campaign that will attempt to "desensitize" the general public about AIDS making patients more willing to ask their physicians about the disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADULT AIDS CLINICAL RESEARCH
  • 批准号：
    3727024
  • 项目类别：
  • 资助金额：
    $0.0万
  • 财政年份：
    --
  • 负责人：
    MICHAEL M LEDERMAN
  • 依托单位：
    CASE WESTERN RESERVE UNIVERSITY
RIFAMPIN, CIPROFLAXACIN, CLOFAZIMINE, ETHAMBUTOL, & AMIKACIN IN HIV+ INDIVIDUALS
PROCYSTEINE IN PATIENTS INFECTED WITH HIV--EFFECTS ON LEVELS OF GLUTATHIONE
PHARMACOLOGY AGENDA
  • 批准号：
    5205123
  • 项目类别：
  • 资助金额：
    $0.0万
  • 财政年份：
    --
  • 负责人：
    MICHAEL M LEDERMAN
  • 依托单位：
    --
海外基金